{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:30:55Z","timestamp":1793493055454,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,20]],"date-time":"2027-10-20T00:00:00Z","timestamp":1823990400000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jdiacomp.2026.109439","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:04:20Z","timestamp":1792422260000},"page":"109439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of continuous glucose monitoring metrics with cardiovascular and kidney outcomes in type 2 diabetes: Data from the GRADE-CGM substudy"],"prefix":"10.1016","volume":"40","author":[{"given":"Mengyao","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Wexler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa S.","family":"Putman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene P.","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahir","family":"Kalim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2026.109439_bb0005","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.2337\/dci21-0035","article-title":"Hemoglobin A1c\u2014Using Epidemiology to Guide Medical Practice: Kelly West Award Lecture 2020","volume":"44","author":"Selvin","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","article-title":"Glycaemic variability in diabetes: clinical and therapeutic implications","volume":"7","author":"Ceriello","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0015","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.2337\/dci23-0048","article-title":"Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus","volume":"46","author":"Sacks","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0020","first-page":"49","article-title":"6. Glycemic goals, hypoglycemia, and hyperglycemic crises: standards of care in diabetes\u20142026","volume":"49","author":"ADA","year":"2026"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0025","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2337\/dci20-0066","article-title":"The Prognostic Value of Time in Range in Type 2 Diabetes","volume":"44","author":"Selvin","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0035","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/dc20-1862","article-title":"Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study","volume":"44","author":"Lu","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0045","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1089\/dia.2022.0447","article-title":"Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTE","volume":"25","author":"Bergenstal","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0050","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2337\/dc25-0716","article-title":"Continuous Glucose Monitoring Metrics Predict All-Cause Mortality in Diabetes: A Real-world Long-term Study","volume":"48","author":"Okuno","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0055","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.2337\/dc21-2298","article-title":"Association of estimated time-in-range capillary glucose levels versus HbA1c with progression of microvascular complications in the Diabetes Control and Complications Trial","volume":"45","author":"Lachin","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0060","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJMoa2200433","article-title":"Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes","volume":"387","author":"GRADE Study Research Group","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0065","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMoa2200436","article-title":"Glycemia reduction in type 2 diabetes \u2014 microvascular and cardiovascular outcomes","volume":"387","author":"The GRADE Study Research Group","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0070","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.2337\/dc13-0356","article-title":"Rationale and design of the Glycemia Reduction Approaches in Diabetes: a Comparative Effectiveness Study (GRADE)","volume":"36","author":"Nathan","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0075","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/dc24-1362","article-title":"Relationship Between Average Glucose Levels and HbA1c Differs Across Racial Groups: A Substudy of the GRADE Randomized Trial","volume":"47","author":"Nathan","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0080","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2337\/dc18-1581","article-title":"Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring","volume":"41","author":"Bergenstal","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0085","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0090","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1007\/s00125-026-06739-w","article-title":"Updated glucose management indicator (GMI) better aligns with HbA1c than current GMI: implications for clinical practice and reporting","volume":"69","author":"Bergenstal","year":"2026","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf9304","article-title":"Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring","volume":"8","author":"Malka","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0100","doi-asserted-by":"crossref","first-page":"S-65","DOI":"10.1089\/dia.2023.0146","article-title":"Personalized glycated hemoglobin in diabetes management: closing the gap with glucose management indicator","volume":"25","author":"Dunn","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0105","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/CIRCOUTCOMES.110.957936","article-title":"Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes","volume":"3","author":"Carson","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0110","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1001\/archinternmed.2011.537","article-title":"Association Between Glycemic Control and Adverse Outcomes in People With Diabetes Mellitus and Chronic Kidney Disease: A Population-Based Cohort Study","volume":"171","author":"Shurraw","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0115","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Action to Control Cardiovascular Risk in Diabetes Study Group","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0120","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0125","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2019010007","article-title":"GFR slope as a surrogate end point for kidney disease progression in clinical trials: a meta-analysis of treatment effects of randomized controlled trials","volume":"30","author":"Inker","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0130","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.2337\/dc14-2898","article-title":"Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!","volume":"38","author":"Hirsch","year":"2015","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jdiacomp.2026.109439_bb0135","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2337\/dc25-3055","article-title":"Comparison of the continuous glucose monitoring profiles of four glucose-lowering medications in the GRADE randomized trial","volume":"49","author":"Bergenstal","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/M16-2855","article-title":"Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial","volume":"167","author":"Beck","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11892-024-01536-4","article-title":"Diabetes Technology in People with Type 2 Diabetes: Novel Indications","volume":"24","author":"Agarwal","year":"2024","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/dia.2024.0579","article-title":"A Randomized Controlled Trial Using Continuous Glucose Monitoring to Guide Food Choices and Diabetes Self-Care in People with Type 2 Diabetes not Taking Insulin","volume":"27","author":"Martens","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0155","doi-asserted-by":"crossref","DOI":"10.1177\/15209156251395036","article-title":"Differences between glycemia estimates from hemoglobin A1c and continuous glucose monitoring and their association with complete blood counts","author":"Tozzo","year":"2026","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2026.109439_bb0160","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726001844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726001844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:20:09Z","timestamp":1793492409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872726001844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1056872726001844"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109439","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of continuous glucose monitoring metrics with cardiovascular and kidney outcomes in type 2 diabetes: Data from the GRADE-CGM substudy","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109439"}}